1. FBH1 Catalyzes Regression of Stalled Replication Forks
Kasper Fugger, Martin Mistrik, Kai J. Neelsen, Qi Yao, Ralph Zellweger, Arne Nedergaard Kousholt, Peter Haahr, Wai Kit Chu, Jiri Bartek, Massimo Lopes, Ian D. Hickson, Claus Storgaard Sørensen 
Cell Reports 
Volume 10, Issue 10, Pages (March 2015)
DOI: /j.celrep
Copyright © 2015 The Authors Terms and Conditions

2. Cell Reports 2015 10, 1749-1757DOI: (10.1016/j.celrep.2015.02.028)
Copyright © 2015 The Authors Terms and Conditions

3. Figure 1 FBH1 Catalyzes Fork Regression In Vitro
(A) Schematic representation of the substrate used in the fork-regression assay.
(B) Indicated concentration of FBH1 was incubated with 5 pM replication fork substrate at 37°C for 30 min and then digested with EcoRI. The reaction products were separated by native PAGE. Gels were dried and processed by PhosphorImaging. RecG, a bona fide bacterial fork regressor, was included as a positive control.
(C) FBH1 wild-type (WT) or helicase dead (HL) were incubated with 5 pM replication fork substrate at 37°C for 30 min and then digested with EcoRI. The reaction products were separated by native PAGE. Gels were dried and processed by PhosphorImaging.
Cell Reports  , DOI: ( /j.celrep )
Copyright © 2015 The Authors Terms and Conditions

4. Figure 2 FBH1 Mediates Fork Regression In Vivo
(A) (Top) U2OS cells were transfected with control or FBH1 siRNA for 48 hr before treatment with 2 mM HU for 4 hr before psoralene crosslinking. Genomic DNA was extracted and prepared for EM, and images were acquired using TEM. (Bottom) Graphical representation of a regressed replication fork; nascent strands (blue arrow), parental strand (black arrow), regressed arm (red arrow).
(B) Quantification and statistical analysis of regressed forks from (A) was performed using Graphpad Prism 6 software. At least 70 replication intermediates were analyzed for each condition. Error bars represent SD from three independent experiments.
(C) U2OS cells were seeded on coverslips and transfected with control or FBH1 siRNA for 48 hr. Cells were then pulse labeled with 10 μM BrdU for 10 min and subsequently treated with HU for 4 hr before fixation. Cells were subjected to immunofluorescence with anti-BrdU antibody, and images were acquired using AxioVert microscope. Image analysis was performed using Volocity software. The scale bar represents 10 μm.
(D) Quantification and statistical analysis of BrdU intensity of samples from (C) were performed using Graphpad Prism 6 software. Boxplot with whiskers representing min to max values.
(E) U2OS cells expressing either WT or helicase mutant (∗HL) GFP-FBH1 in a doxycycline-inducible fashion were seeded on coverslips, and expression was induced or not for 24 hr. Cells were then pulse labeled with 10 μM BrdU for 10 min and subsequently treated or not with HU for 4 hr before fixation. Cells were subjected to immunofluorescence with PCNA and anti-BrdU antibody, and images were acquired using the Olympus ScanR system (as described in the Experimental Procedures section). Quantification and statistical analysis was performed using Graphpad Prism 6 software. Error bars represent SD.
(F) Immunoblotting of samples from (E) showing GFP-FBH1 expression.
Cell Reports  , DOI: ( /j.celrep )
Copyright © 2015 The Authors Terms and Conditions

5. Figure 3
FBH1 Mediates DNA DSB Checkpoint Signaling through Its Helicase Activity following Replication Fork Stalling
(A) U2OS/shFBH1 cells were either induced or not with doxycycline for 48 hr before treatment with 2 mM HU. Cells were collected at the indicated time points and subjected to immunoblotting with the indicated antibodies.
(B) U2OS cells were transfected with FBH1 or MUS81 siRNA for 48 hr. Cells were treated with 2 mM HU for 4 hr, collected, and subjected to immunoblotting with the indicated antibodies.
(C) U2OS cells were either untreated or pre-treated with an ATM inhibitor (10 μM) for 30 min prior to treatment with either 2 mM HU for 4 hr or 1 μM CPT for 1 hr. Cells were collected and subjected to immunoblotting with the indicated antibodies.
(D) U2OS cells were transfected with UNC or CtIP siRNA for 48 hr. Cells were either left untreated or treated with 2 mM HU for 4 hr, collected, and subjected to immunoblotting with the indicated antibodies.
(E) U2OS cells expressing either human WT or ∗HL GFP-FBH1 in a doxycycline-inducible fashion were depleted using siFBH1 targeting in the 3′ UTR for 48 hr. Expression of GFP-FBH1 was induced 24 hr post-transfection. Cells were either left untreated or treated with 2 mM HU for the indicated times, collected, and subjected to immunoblotting.
(F) MESCs, either FBH1 WT or HL were treated with 0.5 mM HU, collected at the indicated time points, and subjected to immunoblotting with the indicated antibodies. Asterisk indicates a cross-reacting band.
Cell Reports  , DOI: ( /j.celrep )
Copyright © 2015 The Authors Terms and Conditions

6. Figure 4 FBH1 Promotes Checkpoint Control and Genome Integrity
(A) U2OS/shFBH1 were either induced or not with doxycycline for 48 hr before treatment with 2 mM HU for 16 hr. Cells were released from the HU block into fresh media containing nocodazole (100 ng/ml) and collected at the indicated time points, stained with phospho-H3-S10 antibody, and analyzed by flow cytometry. Statistical analysis was performed using Graphpad Prism 6 software. Error bars represent SD.
(B) TIG3 cells were seeded on coverslips and transfected with UNC or FBH1 siRNA for 48 hr before treatment with HU for 18 hr. Cells were released for 24 hr, fixed, and subjected to immunofluorescence as described in the Experimental Procedures section. Single-cell images of 53BP1 foci were acquired using the ScanR system (see Experimental Procedures). The scale bar represents 10 μm.
(C) Quantification of 53BP1 foci from at least 5,000 G1 cells. Statistical analysis was performed using Graphpad Prism 6 software. Error bars represent mean with 95% CI.
(D) Model depicting how FBH1 mediates fork processing and promotes checkpoint signaling (see text for details).
Cell Reports  , DOI: ( /j.celrep )
Copyright © 2015 The Authors Terms and Conditions